US20030055067A1 - Antifungal composition with enhanced bioavailability - Google Patents

Antifungal composition with enhanced bioavailability Download PDF

Info

Publication number
US20030055067A1
US20030055067A1 US10/114,612 US11461202A US2003055067A1 US 20030055067 A1 US20030055067 A1 US 20030055067A1 US 11461202 A US11461202 A US 11461202A US 2003055067 A1 US2003055067 A1 US 2003055067A1
Authority
US
United States
Prior art keywords
liquid
suspension
sorbitan
effective amount
liquid suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/114,612
Inventor
Stefan Sharpe
Joel Sequeira
David Harris
Shashank Mahashabde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US28113901P priority Critical
Application filed by Merck Sharp and Dohme Corp filed Critical Merck Sharp and Dohme Corp
Priority to US10/114,612 priority patent/US20030055067A1/en
Publication of US20030055067A1 publication Critical patent/US20030055067A1/en
Assigned to SCHERING CORPORATION reassignment SCHERING CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HARRIS, DAVID, SEQUEIRA, JOEL, SHARPE, STEFAN, MAHASHABDE, SHASHANK
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20030055067(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Abandoned legal-status Critical Current

Links